4.6 Article

Impact of COVID-19 on Primary Care Quality Measures in an Academic Integrated Health System

期刊

JOURNAL OF GENERAL INTERNAL MEDICINE
卷 37, 期 5, 页码 1161-1168

出版社

SPRINGER
DOI: 10.1007/s11606-021-07193-7

关键词

COVID-19; primary care; preventative screening; chronic disease management

向作者/读者索取更多资源

Health screening rates decreased during the early stages of the COVID-19 pandemic and did not fully recover to pre-pandemic levels by July 2020. Further research is needed to understand the long-term impacts of delayed health screenings.新的干预措施应被考虑,以扩大远程预防性健康服务。
Background Access to primary care was hindered by the coronavirus disease 2019 (COVID-19) pandemic. Objective Evaluate changes in health screening rates before and during the pandemic. Design Retrospective analysis of health maintenance and disease management screening rates among primary care patients before and during the pandemic. Participants Over 150,000 patients of a large, academic health system. Main Measures Six quality measures were analyzed: colon cancer, breast cancer, cervical cancer, diabetes Hgb A1C, diabetes eye, and diabetes nephropathy monitoring. Based on US Preventative Services Task Force screening guidelines, we determined which patients were due for at least one of the quality measures. We tracked completion rates during three time periods: pre-pandemic (January 1-March 3, 2020), stay-at-home (March 4-May 8, 2020), and phased reopening (May 9-July 8, 2020). Differences in quality measure completion rates were evaluated using mixed-effects logistic regression models. Key Results Compared to pre-pandemic rates, completion of all health screenings declined during the stay-at-home period: mammograms (OR: 0.34; 95% CI: 0.31-0.37), cervical cancer (OR: 0.83; 95% CI: 0.76-0.91), colorectal cancer (OR: 0.25; 95% CI: 0.23-0.28), diabetes eye (OR: 0.34; 95% CI: 0.29-0.41), diabetes Hgb A1c (OR: 0.41; 95% CI: 0.37-0.46), and diabetes nephropathy (OR: 0.46, 95% CI: 0.41-0.53). During phased reopening, completion of all quality measures increased compared to the stay-at-home period, except for cervical cancer screening (OR: 0.83; 95% CI: 0.76-0.92). There was a persistent reduction in completion of all quality measures, except for diabetic nephropathy monitoring (OR: 0.99; 95% CI: 0.89-1.09), during phased reopening compared to pre-pandemic. Conclusions Healthcare screening rates were reduced during the early part of the COVID-19 pandemic and did not fully recover to pre-pandemic rates by July 2020. Future research should aim to clarify the long-term impacts of delayed health screenings. New interventions should be considered for expanding remote preventative health services.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据